|
FY2025
12 months to Dec 31, 2025
|
FY2023
12 months to Dec 31, 2023
|
FY2024
12 months to Dec 31, 2024
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Research and development expenses – related parties | |||||
| Nonrelated Party | |||||
| Related Party | |||||
| General and administrative expenses | |||||
| Nonrelated Party | |||||
| Related Party | |||||
| Operating loss | |||||
| Financing expenses, net: | |||||
| Expenses related to convertible loan terms – related parties | |||||
| Expenses related to MY PLANT options | |||||
| Expenses related to revaluation of investments | |||||
| Other financing expenses, net | |||||
| Financing expenses, net | |||||
| Net loss | |||||
| Loss per common stock, basic | |||||
| Loss per common stock, diluted | |||||
| Basic weighted average number of shares of Common Stock outstanding | |||||
| Comprehensive loss: | |||||
| Other comprehensive loss attributable to foreign currency translation | |||||
| Comprehensive loss | |||||
Loading...